Gemcitabine Hydrochloride for SARS-CoV-2
Reported by Gemini Smith | February 23rd, 2024 @ 02:15 AM
A 2'-deoxycytidine hydrochloriode with geminal fluoro substituents in the 2'-position is gemcitabine hydrochloride. This deoxycytidine analog can stop the proliferation of multiple cell lines, including BxPC-3, Mia Paca-2, PANC-1, PL-45, and AsPC-1 cells. It also prevents DNA synthesis and repair. This substance has been utilized to treat a number of carcinomas, such as non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer, since it inhibits ribonucleotide reductase. According to studies, gemcitabine hydrochloride can be used to treat or prevent viral illnesses.
2-3-3-sars-cov-2-spike-pseudovirus-based-neutralization-assay-1.jpg
No comments found
Please Sign in or create a free account to add a new ticket.
With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.
Create new ticket
Create your profile
Help contribute to this project by taking a few moments to create your personal profile. Create your profile »
.
People watching this ticket
Gemini Smith
Attachments
-
2-3-3-sars-cov-2-spike-pseu...
22.4 KB